Stroke News

Abbott announced FDA clearances for two components of the company’s life support system.

Statin therapy may improve risk for stroke or transient ischemic attack among patients with atrial fibrillation compared with nonuse, regardless of concomitant anticoagulant use, a speaker reported.

Comorbid acute ischemic stroke and COVID-19 increased the rate of stroke mortality in 2020, researchers reported.

The FDA has granted 510(k) clearances to seven triage and notification findings of varying conditions on chest X-ray and head CT images, according to a manufacturer-issued press release.

Nearly half of people living with mood disorders such as anxiety and depression after stroke did not receive mental health treatment, and those being treated tend to only receive medication, researchers reported.

Among older patients with atrial fibrillation and dementia, apixaban was associated with lower risk for stroke and major bleeding vs. dabigatran, rivaroxaban or warfarin, researchers reported.

Smoking consistently after acute ischemic stroke was associated with increased risk for CV events and death compared with never smoking, researchers reported.

Use of early vs. delayed antihypertensive treatment after onset of acute ischemic stroke to reduce risk for composite case-fatality and major disability at 3 months.

Assessing safety of lowering BP in acute stroke after successful mechanical thrombectomy.

For every 500 extra steps per day, or an additional one-quarter mile walked, adults aged 70 years or older could reduce risk for a CVD event by approximately 14%, a speaker reported.